Literature DB >> 12871965

Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge.

J Campisi1, M K Hansen, K A O'Connor, J C Biedenkapp, L R Watkins, S F Maier, M Fleshner.   

Abstract

Peripheral administration of a variety of inflammatory stimuli, such as endotoxin or cytokines, induces an orchestrated set of brain-mediated events referred to as the sickness response. The mechanism for how immune products signal the brain is not clear, but accumulating evidence supports the existence of neural as well as blood-borne pathways. Although endotoxin or cytokine administration results in sickness responses, few data exist regarding the role of circulating endotoxin or cytokines in the induction of sickness during a real bacterial infection. Thus the present studies examined whether subcutaneously administered Escherichia coli can activate sickness responses and whether circulating endotoxin and/or proinflammatory cytokines are a prerequisite for these responses. Male Sprague-Dawley rats were injected subcutaneously with one of three doses (2.5 x 10(7), 2.5 x 10(8), 2.5 x 10(9) colony-forming units) of replicating E. coli, a ubiquitous bacterial strain, or vehicle. Core body temperature (Tc) and activity were measured for 3 days after the injection. A second set of groups of animals were killed 3, 6, 12, 18, 24, and 48 h after the injection, and blood samples and brains were collected. Injections dose dependently and consistently increased Tc and decreased activity, with increases in Tc beginning 4 h after the injection. In addition, E. coli significantly increased serum interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha and brain IL-1beta levels beginning at the 6-h time point. Corticosterone and endotoxin were first elevated in the circulation at 3 and 18 h after the injection, respectively. Because fever onset preceded brain cytokine induction, we also examined cytokine levels in the serum, brain, and inflammation site 2 and 4 h after injection. Cytokines were elevated at the inflammation site but were not detectable in the serum or brain at 2 and 4 h. We conclude that subcutaneous injection of replicating E. coli induces a consistent and naturalistic infection that includes features of the sickness response as well as increases in circulating, brain, and inflammation site tissue cytokines. In addition, injection of replicating E. coli produces a robust fever and corticosterone response at a time when there are no detectable increases in circulating cytokines or endotoxin. These results suggest that elevated levels of circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response. Therefore, fever, activity reduction, and corticosterone elevation induced by E. coli infection may have been evoked by a neural, rather than a humoral, pathway from the periphery to the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871965     DOI: 10.1152/japplphysiol.00371.2003

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

1.  Fos expression in the rat brain after intraperitoneal injection of Staphylococcus enterotoxin B and the effect of vagotomy.

Authors:  Xi Wang; Bai-Ren Wang; Xi-Jing Zhang; Xiao-Li Duan; Xiang Guo; Gong Ju
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 2.  Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways?

Authors:  Ning Quan
Journal:  Mol Neurobiol       Date:  2008-06-19       Impact factor: 5.590

3.  Antisomnogenic cytokines, quality of life, and chronic rhinosinusitis: a pilot study.

Authors:  Jeremiah A Alt; Nathan B Sautter; Jess C Mace; Kara Y Detwiller; Timothy L Smith
Journal:  Laryngoscope       Date:  2013-10-22       Impact factor: 3.325

Review 4.  Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders.

Authors:  Monika Fleshner; Matthew Frank; Steven F Maier
Journal:  Neuropsychopharmacology       Date:  2016-07-14       Impact factor: 7.853

5.  Febrile response induced by cecal ligation and puncture (CLP) in rats: involvement of prostaglandin E2 and cytokines.

Authors:  Maria José Figueiredo; Denis Melo Soares; Denis de Melo Soares; Juliano Manvailer Martins; Renes de Resende Machado; Carlos Arterio Sorgi; Lucia Helena Faccioli; Miriam Cristina Contin de Melo; Miriam Cristina Contin de Melo; David do Carmo Malvar; Glória E P Souza
Journal:  Med Microbiol Immunol       Date:  2011-12-28       Impact factor: 3.402

6.  Location-specific activation of the paraventricular nucleus of the hypothalamus by localized inflammation.

Authors:  Natalya Belevych; Krystal Buchanan; Qun Chen; Michael Bailey; Ning Quan
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

7.  A crucial role for IL-6 in the CNS of rats during fever induced by the injection of live E. coli.

Authors:  Denis M Soares; Maria José Figueiredo; Juliano Manvailer Martins; Renes Resende Machado; Carlos Sorgi; Lucia Helena Faciolli; José C Alves-Filho; Fernando Q Cunha; Glória E P Souza
Journal:  Med Microbiol Immunol       Date:  2011-06-05       Impact factor: 3.402

8.  Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and cyclooxygenase-2 in the blood and brain.

Authors:  H Zhang; S Ching; Q Chen; Q Li; Y An; N Quan
Journal:  Neuroscience       Date:  2008-10-01       Impact factor: 3.590

9.  Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection.

Authors:  Ruth M Barrientos; Matthew G Frank; Amy M Hein; Emily A Higgins; Linda R Watkins; Jerry W Rudy; Steven F Maier
Journal:  Brain Behav Immun       Date:  2008-07-11       Impact factor: 7.217

Review 10.  Frank A. Beach award: programming of neuroendocrine function by early-life experience: a critical role for the immune system.

Authors:  Staci D Bilbo
Journal:  Horm Behav       Date:  2013-03-06       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.